Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115232) titled 'Exploring cognitive function changes in patients with malignant hematological diseases' on Dec. 24, 2025.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital)
Condition:
Malignant hematological diseases
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-12-25
Target Sample Size: Observation Group of Malignant Hematological Diseases:50;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=301083
Published by HT ...